In the IMPACT trial, pemvidutide achieved mean weight losses of 4.8% and 5.8% with 1.2 and 1.8 mg doses respectively at 24 weeks, compared to 0.5% with placebo, with weight loss curves showing no evidence of plateauing, suggesting continued benefit with longer treatment [49-51]
Visit Fill out a Health Care Proxy form If you have not already filled out a Health Care Proxy form, we recommend you do now
What Happens If You Stop Taking GLP-1
Made with natural ingredients to soothe and balance your gut, its the perfect companion for anyone using GLP-1 medications or looking to feel their best every day
Brian Wojeck, an obesity medicine specialist at the Yale School of Medicine, likened it to what happens after bariatric surgery, in which patients often experience temporary shedding due to stress and rapid metabolic change